|
发表于 7-10-2009 11:16 PM
|
显示全部楼层
最近大股东出了不少货了
| 公司最近的內部交易記錄 |  |
日期 | 名字/職位 | 類型 | 股數 | 價格 | 2009/9/25 | BIANCO JAMES A
Director, CEO | 賣出 | 318621 | 1.1918 | 2009/9/25 | BIANCO LOUIS A
EVP, Finance & Administration | 賣出 | 105580 | 1.2302 | 2009/9/25 | Eramian Daniel G
EVP, Corporate Communications | 賣出 | 104276 | 1.25 | 2009/9/25 | PHILIPS CRAIG
President | 賣出 | 211500 | 1.2409 | 2009/9/25 | SINGER JACK W
Director, EVP, Chief Medical Officer | 賣出 | 101380 | 1.2302 | 2009/9/11 | BIANCO JAMES A
Director, CEO | 賣出 | 1366108 | 1.43 | 2009/8/14 | NUDELMAN PHILLIP M PHD
Director | 賣出 | 164000 | 1.57 | 2009/8/12 | LOVE RICHARD L
Director | 賣出 | 70000 | 1.64 | 2009/8/10 | BAUER JOHN H
Director | 賣出 | 80000 | 1.5 | 2009/6/2 | BAUER JOHN H
Director | 賣出 | 25000 | 1.76 |
|
|
|
|
|
|
|
|
|
发表于 7-10-2009 11:16 PM
|
显示全部楼层
原帖由 雨若情 于 7-10-2009 11:13 PM 发表 
我下一站就去maldives
马来西亚有海边的地方都去完咯。
sinpadan真的很美。
喜欢看鱼看海的朋友一定要去沙巴走走。
pulau pangkok岛隔壁小岛有个个resort叫:pulau pangkok resort
的地方也要去去。不然 ...
刚生完就丢下小孩自己去玩? |
|
|
|
|
|
|
|
发表于 7-10-2009 11:20 PM
|
显示全部楼层
今晚的CVM 。。。 這只是熱身而已。。。
接下來。。 還有後續。。。。  |
|
|
|
|
|
|
|
发表于 7-10-2009 11:21 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 7-10-2009 11:25 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 7-10-2009 11:26 PM
|
显示全部楼层
avii几天前跌到1.51时有买过10000。。1.61就卖了。。没想到1.9了。。
有机会跌回会再买。。 |
|
|
|
|
|
|
|
发表于 7-10-2009 11:32 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 8-10-2009 01:16 AM
|
显示全部楼层
没什么消息。。。。volume 非常 高。。。。
各位 没信心。。。。
觉得太久。。。
想 套现出来的。。。。迟些再买的。。。
这是机会。。。?。 |
|
|
|
|
|
|
|
发表于 8-10-2009 09:02 AM
|
显示全部楼层
Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 10/8/09
Resistance Levels: $1.19, $1.28, $1.31
Support Levels: $1.00, $0.97, $0.91, $0.87

Cell Therapeutics, Inc ( CTIC ) made a textbook technical reversal off the 200 day moving average today. The stock traded below $0.87 for a split second and then the short covering came in. CTIC then broke through $0.96 ( the high of the day ) and ripped back to the 10 day moving average on heavy volume. CTIC is trading up a bit in after hours so expect tomorrow to be another active day. Resistance continues to be located at the 10 day moving average which tomorrow will be around $1.17. A close over back over this level would be very bullish going forward. As always, I like pullbacks to the 200 day moving average again.
XXXXXXXXXXXXXXXXXXXXX
Cell Therapeutics, Inc. (CTIC) - CTIC hit the 200 day moving averagethis morning, bounced, and then broke through the high of the daylocated at $0.96. CTIC then rallied back near the $1.20 resistancearea. I continue to like pullbacks to the 200 day moving average. Iwould also buy a break up through $1.20 for a quick trade.
[ 本帖最后由 葉芬 于 8-10-2009 09:05 AM 编辑 ] |
|
|
|
|
|
|
|
发表于 8-10-2009 10:16 AM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 9-10-2009 03:21 AM
|
显示全部楼层
原帖由 napster 于 7-10-2009 11:25 PM 发表 
不是那个帖子,哪有那么多人弃马投美。。。
maldives 很贵的。你可以到我的blog 去看maldives 网站连接,有几个不错的游记分享。
叶芬也想去。你们可以相约一起去
11月头去langkawi,有好介绍吗?好像水上resort呀之类的。O(∩_∩)O谢谢
Maldives等我有100万时去。。 |
|
|
|
|
|
|
|
发表于 13-10-2009 11:15 AM
|
显示全部楼层
Cell Therapeutics, Inc. (CTIC) - CTIC looks poised to close over the 10 day moving average on Monday, located at $1.14. Rallies back to the 50 day moving average ( currently $1.44 ) should be sold. |
|
|
|
|
|
|
|
发表于 14-10-2009 12:40 PM
|
显示全部楼层
Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 10/14/09
Resistance Levels: $1.20, $1.30, $1.57
Support Levels: $1.11, $1.08, $1.00, $0.89

Cell Therapeutics, Inc. (CTIC) closed right at the 10 day moving average on Tuesday, something worth watching tomorrow. In order for this recent rally to continue, CTIC must go higher and break through $1.20. Failure to hold the 10 day moving average could spark another sell off back to the 200 day moving average. If the 200 day moving average ( $0.89 ) is retested, I would be a buyer. |
|
|
|
|
|
|
|
发表于 15-10-2009 04:20 AM
|
显示全部楼层
NEW YORK, Oct 14 (Reuters) - CIT Group Inc (CIT.N) is getting closer to finalizing the terms of a new loan that would give them an additional $3 billion to $6.5 billion, two sources familiar with the matter said on Wednesday.
The loan, being arranged by Bank of America, could be finalized as soon as this week, the sources said, declining to be identified because talks are private. One of the sources said the situation was still fluid and it could be delayed.
CIT would use most of the additional money, except about $500 million, to repay existing debt, the sources said.
The loan would work as a secured facility in case of a successful exchange offer by the lender, or a debtor-in-possession loan if CIT has to file for bankruptcy, one source said.
CIT spokesman Curt Ritter declined to comment.
http://www.reuters.com/article/a ... idUSWEN468220091014
要买快点买, 好消息来的  |
|
|
|
|
|
|
|
发表于 15-10-2009 04:30 AM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 15-10-2009 07:32 PM
|
显示全部楼层
怎么有那么多那么天真的CTIC迷呢???
这根本就是只烂股,怎么还是有一大堆人在里面发梦呢
要期待一只烂股好过把这些心思花在一些贵点股的吧 |
|
|
|
|
|
|
|
发表于 19-10-2009 09:43 AM
|
显示全部楼层
Cell Therapeutics, Inc. (CTIC) - I continue to watch CTIC closely. The stock has resistance at $1.20 and I would be a buyer when CTIC breaks up through that level. |
|
|
|
|
|
|
|
发表于 22-10-2009 06:08 PM
|
显示全部楼层
Cell Therapeutics Says Pixantrone Studies Show High Rates Of Complete Remission In Relapsed/refractory Aggressive, Indo
Cell Therapeutics Says Pixantrone Studies Show High Rates Of Complete Remission In Relapsed/refractory
Aggressive, Indolent NHL Patients - Quick Facts
Thu Oct 22 02:07:00 2009
EDT
(RTTNews) - Cell Therapeutics, Inc. (CTIC) announced that Richard Van der Jagt of the Ottawa General
Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of the company's
pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission
in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma, or NHL, patients.
The company revealed 70% CR/CRu rate in a phase II trial in patients treated with pixantrone plus
FPD-R regimen in relapsed/refractory indolent NHL. The company also announced 47% CR/CRu rate in a
phase II trial in patients treated with CPOP regimen for patients that failed CHOP regimen with relapsed/refractory
aggressive NHL. Cell Therapeutics further disclosed 35% CR rate in a phase III trial in patients treated
with pixantrone plus rituximab in relapsed/refractory indolent NHL.
For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
CTIC,
BREAKING_NEWS, US, CORPORATE_NEWS,
This content is for use with eSignal products by authorized persons only. Any reference; link, frame,
or other use of this material without the explicit permission of eSignal is prohibited. |
|
|
|
|
|
|
|
发表于 23-10-2009 03:47 PM
|
显示全部楼层
23/10/09
Cell Therapeutics, Inc. (CTIC) - CTIC continues to hang around the 10 day moving average. The volume remains very light compared to the average over the past 5 months. I would be a buyer on a close over $1.20. $1.20 seems to be a heavy resistance level for CTIC. |
|
|
|
|
|
|
|

楼主 |
发表于 30-10-2009 10:14 AM
|
显示全部楼层
|
|
|
|
|
|
| |
本周最热论坛帖子
|